SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-117138
Filing Date
2021-04-15
Accepted
2021-04-15 07:43:58
Documents
3
Period of Report
2021-04-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d135458d8k.htm 8-K 18363
2 EX-99.1 d135458dex991.htm EX-99.1 10156
3 GRAPHIC g135458g0414230755000.jpg GRAPHIC 5474
  Complete submission text file 0001193125-21-117138.txt   37414
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40287 | Film No.: 21827309
SIC: 2836 Biological Products, (No Diagnostic Substances)